This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Epidemiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • the life-time prevalence of migraine has been stated as (1):
    • 8% in men
    • 25% in women
    • prevalence of migraine in the previous year was 6% in men and 15% in women
  • 80% patients have their first attack before the age of 30
  • prevalence of migraine increases until age 40 and then declines
  • 15% of females with migraine only have attacks around the time of menstruation
  • the prevalence of common migraine (without aura) is three times that of classical migraine (with aura) (1)

The socioeconomic cost of migraine runs to billions of pounds in the UK (2), due to:

  • lost working days
  • reduced productivity at work

Since the disorder tends to remit with older age, an onset of migraine after the age of 50 years should arouse suspicion of a secondary headache disorder (4)

Reference:

  1. Rasmussen BK et al.Epidemiology of headache in a general population-a prevalence study. J Clin Epidemiol. 1991;44(11):1147-57.
  2. Cull RE et al. The economic cost of migraine. British Journal of Medical Economics 1992; 2:102-15.
  3. Drug and Therapeutics Bulletin 1998; 36(6):41-4.
  4. Ashina M. Migraine. N Engl J Med 2020;383:1866-76. DOI: 10.1056/NEJMra1915327

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.